Jia Yuan Law Offices has recruited Mo Huan as a partner in its Shanghai office, focusing on intellectual property and healthcare. Mo told China Business Law Journal: “This year, companies involved in innovative drugs, medical equipment, biotechnology and vaccine research, and development in the primary and secondary markets, have drawn investors’ attention. As a result, financing and intellectual property licensing in the pharmaceutical industry are on the rise.”
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
